Value of intraoperative neck margin analysis during whipple for pancreatic adenocarcinoma: A multicenter analysis of 1399 patients

Annals of Surgery

Volumn 260, Issue 3, 2014, Pages 494-503

  Kooby, David A ^a   Lad, Neha L ^a   Squires, Malcolm H ^a   Maithel, Shishir K ^a   Sarmiento, Juan M ^a   Staley, Charles A ^a   Volkan Adsay, N ^a   El Rayes, Bassel F ^a   Weber, Sharon M ^b   Winslow, Emily R ^b   Cho, Clifford S ^b   Zavala, Kathryn A ^b   Bentrem, David J ^c   Knab, Mark ^c   Ahmad, Syed A ^d   Abbott, Daniel E ^d   Sutton, Jeffrey M ^d   Kim, Hong Jin ^e   Yeh, Jen Jen ^e   Aufforth, Rachel ^e   Scoggins, Charles R ^f   Martin, Robert C ^f   Parikh, Alexander A ^g   Robinson, Jamie ^g   Hashim, Yassar M ^h   Fields, Ryan C ^h   Hawkins, William G ^h   Merchant, Nipun B ^g   more..

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f University of Louisville School of Medicine   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

frozen section; local recurrence; overall survival; pancreatic neoplasm; pancreaticoduodenectomy

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; CLINICAL TRIAL; FEMALE; FROZEN SECTION; HUMAN; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATHOLOGY; PERINEUM; RETROSPECTIVE STUDY; SURVIVAL; TUMOR INVASION; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FROZEN SECTIONS; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PERINEUM; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84906056097     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000890     Document Type: Conference Paper

References (31)

1. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenec- tomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199-1210; discussion 1210-1211.
2. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817-1825.
3. Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691-1703.
4. Bickenbach KA, Gonen M, Tang LH, et al. Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Ann Surg Oncol. 2012;19:1663-1669.
5. Merchant NB, Rymer J, Koehler EA, et al. Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll Surg. 2009;208:829-838; discussion 838-841.
6. Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al. Pancreatic ductal adenocar-cinoma: long-term survival does not equal cure. Surgery. 2012;152:S43-S49.
7. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567-579.
8. Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarci-noma. Br J Surg. 2004;91:586-594.
9. Kooby DA, Gillespie TW, Liu Y, et al. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base. Ann Surg Oncol. 2013;20:3634-3642.
10. Dillhoff M, Yates R, Wall K, et al. Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer. J Gastrointest Surg. 2009;13:825-830.
11. Hernandez J, Mullinax J, Clark W, et al. Survival after pancreaticoduodenec-tomy is not improved by extending resections to achieve negative margins. Ann Surg. 2009;250:76-80.
12. Fatima J, Schnelldorfer T, Barton J, et al. Pancreatoduodenectomy for duc-tal adenocarcinoma: implications of positive margin on survival. Arch Surg. 2010;145:167-172.
13. Lad NL, Squires MH, Maithel SK, et al. Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy? Ann Surg Oncol. 2013;20:3626-3633.
14. Hermanek P, Wittekind C. The pathologist and the residual tumor (R) classification. Pathol Res Pract. 1994;190:115-123.
15. Jamieson NB, Foulis AK, Oien KA, et al. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2010;251:1003-1010.
16. Konstantinidis IT, Warshaw AL, Allen JN, et al. Pancreatic ductal adenocarci-noma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg. 2013;257:731-736.
17. Schmidt CM, Glant J, Winter JM, et al. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery. 2007;142:572-578; discussion 578-580.
18. Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancre-Atoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247:456-462.
19. Tseng JF, Pisters PW, Lee JE, et al. The learning curve in pancreatic surgery. Surgery. 2007;141:456-463.
20. Pang TC, Wilson O, Argueta MA, et al. Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility. Pathology. 2014;46:188-192.
21. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758-768.
22. Butturini G, Stocken DD, Wente MN, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-Analysis of randomized controlled trials. Arch Surg. 2008;143:75-83; discussion 83.
23. Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651-1660.
24. Liszka L, Pajak J, Zielinska-Pajak E, et al. Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adeno-carcinoma of the pancreas treated with pancreaticoduodenectomy. Pathology. 2010;42:138-146.
25. Adsay NV, Basturk O, Altinel D, et al. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol. 2009;22:107-112.
26. Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade modular pan-creatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg. 2007;204:244-249.
27. Kooby DA, Hawkins WG, Schmidt CM, et al. A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg. 2010;210:779-785, 786-787.
28. Hishinuma S, Ogata Y, Tomikawa M, et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10:511-518.
29. Turrini O, Ewald J, Barbier L, et al. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg. 2013;257:726-730.
30. Verbeke CS. Resection margins in pancreatic cancer. Surg Clin North Am. 2013;93:647-662.
31. Katz MH, Merchant NB, Brower S, et al. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011;18:337-344.